- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04935814
Cardiac Output Response to Vasopressin Infusion In Abdominal Surgery Patients Under Mechanical Ventilation (CORVaso)
Cardiac Output Response to Vasopressin Infusion In Abdominal Surgery Patients Under Mechanical Ventilation: A Clinical Pharmacodynamics Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Maintaining hemodynamic stability is one of the main objectives of the anesthesiologist or the intensivist, either in the ICU or the OR. This consists of optimizing cardiac output to ensure satisfactory systemic perfusion during the peri-operative period or the ICU stay. The occurrence of oxygen debt (mismatch between oxygen consumption and transport) and/or tissue hypoperfusion are key factors in the development of organ failure. Numerous studies have shown in recent years that individualized hemodynamic optimization (cardiac output and organ perfusion pressure) reduces the risk of postoperative and ICU morbidity and mortality.
Monitoring of cardiac output and stroke volume is a valuable and essential aid in determining the therapies to be used for this optimization, whether it involves volume expansion or the use of a vasopressor or even inotropic agent.
Several vasopressor therapies have been available to date. Norepinephrine is currently the reference in the treatment of vasoplegic shock states, but also in the operating room during major surgery or in fragile patients. Other molecules are currently available and are used in a disparate manner, according to the habits of each practitioner, sometimes outside regulatory rules, not following international recommendations concerning the pathology in question: adrenaline, dopamine, phenylephrine, terlipressin...
Vasopressin (D-arginine-D-vasopressin) is an endogenous hormone synthesized by the hypothalamus (peptide composed of 9 amino acids) which has an antidiuretic renal action through its V2 receptor but also a vasoconstriction activity through its V1a receptor, at the level of the smooth muscles of the vascular wall. It also participates in the stimulation of catecholamine secretion by the adrenal medulla. Vasopressin is commercially available under the name "argipressin". It is currently indicated as an adjunct to other vasopressors such as norepinephrine in refractory septic shock to maintain satisfactory hemodynamic stability.
However, its vasoconstrictive and hemodynamic effects, including its influence on cardiac output, have never been studied to date and to the knowledge of investigators. In particular, there are no studies showing the influence of this molecule on mean systemic pressure and venous return resistance, which are fundamental determinants of its impact on left heart function and thus on cardiac output.
In this study, the investigators propose to explore the hemodynamic variations induced by vasopressin and its influence on cardiac output, mean systemic pressure, and venous return resistance measured through cardiopulmonary interactions, according to the approach proposed by Guyton.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France
- CHU
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults above 18
- Planned for a major abdominal surgery under general anesthesia
- Under mechanical ventilation
- Presence of a central venous and arterial lines allowing transpulmonary thermodilution cardiac output measurement
- Patient's consent with a social insurance
Exclusion Criteria:
- Do not consent to participate
- History of heart attack, arteriopathy or aneurysm
- Contraindication to use transpulmonary thermodilution to measure cardiac output :
- coagulopathy
- cardiac arrythmia
- presence of pace-maker or defibrillator
- severe valvulopathy
- Patients with Acute Respiratory Distress Syndrome (according to Berlin criteria)
- History of arterial hypertension (treated or not)
- History of seizure, chronic headache, asthma or heart failure
- Left Ventricular Ejection Fraction (LVEF) < 45% or right ventricular dysfunction
- History of pulmonary lobectomy or surgery
- History of restrictive or obstructive pulmonary disease
- Body Mass Index (BMI) < 15 or > 40 kg/m²
- Pregnancy
- Known allergy to vasopressin
- Patients under protection of justice (guardianship, curators...)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Continuous vasopressin infusion
After general anesthesia, patients will receive a continuous infusion of vasopressin in order to improve mean arterial pressure by 20 mmHg.
|
Once vasopressin infusion started, patients positions will be randomized: Trendelenburg (-30°), anti Trendelenburg (+30°) and supine position (0°).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Variation of cardiac output after an infusion of vasopressin at different levels of cardiac preload
Time Frame: 15 minutes after position change
|
Using a thermodilution method, cardiac output will be measured and recorded at different levels of cardiac preload obtained by changing patient's position (Trendelenburg, anti-Trendelenburg and supine position).
|
15 minutes after position change
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Variation of mean systemic filling pressure and venous return after an infusion of vasopressin at different levels of cardiac preload
Time Frame: 15 minutes after position change
|
Mean systemic filling pressure will be determined by plotting the venous return curve using the cardiopulmonary interaction described by Guyton, by changing patient's position (Trendelenburg, anti-Trendelenburg and supine position).
|
15 minutes after position change
|
Variation of central venous pressure after an infusion of vasopressin at different levels of cardiac preload
Time Frame: 15 minutes after position change
|
Using a central venous catheter, the central venous pressure will be determined.
|
15 minutes after position change
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CORVaso / RBHP 2021 GODET 2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on General Anesthesia
-
Universidad de AntioquiaCompletedAnesthesia, General | Anesthesia, IntravenousColombia
-
Children's Hospital of PhiladelphiaErasmus Medical Center; University of Texas Southwestern Medical Center; Children... and other collaboratorsCompletedPediatric Anesthesia | General Anesthesia | ElectroencephalographyUnited States, Australia, Switzerland, China, Netherlands
-
University Hospital, SaarlandCompletedGeneral Anesthesia | Regional Anesthesia | Immune FunctionGermany
-
Antalya Training and Research HospitalCompletedAnesthesia, General | Anesthesia, Spinal | Umbilical CordTurkey
-
Tanta UniversityRecruitingSpinal Anesthesia | General Anesthesia | Inguinal Herniorrhaphy | NeonatesEgypt
-
Nordic Pharma SASCompletedSpinal Anesthesia | Outpatient Surgery | Short General AnesthesiaFrance
-
Samsung Medical CenterUnknownGeneral Anesthesia | Total Intravenous Anesthesia | Bispectral Index MonitoringKorea, Republic of
-
Armed Forces Hospital, PakistanCompletedGeneral Anesthesia | Epidural AnesthesiaPakistan
-
University of Wisconsin, MadisonCompletedGeneral Anesthesia | Intravenous AnesthesiaUnited States
-
Samsun UniversityCompletedAnesthesia | Regional Anesthesia | Anesthesia ManagementTurkey
Clinical Trials on Vasopressin, Arginine
-
Radboud University Medical CenterNot yet recruitingBipolar Disorder | Concentration Ability Impaired | Nephrogenic Diabetes Insipidus | Lithium Toxicities | Lithium - Induced NephropathyNetherlands
-
Columbia UniversityCompletedHypertension | End Stage Renal DiseaseUnited States
-
Hangang Sacred Heart HospitalAsan Medical CenterUnknownBurn SurgeryKorea, Republic of
-
Bowdoin CollegeNational Institute of Mental Health (NIMH); MaineHealthCompleted
-
University of Maryland, BaltimoreRecruiting
-
Medical College of WisconsinCompletedCongenital Heart Disease | Single-ventricle | Circulatory Perfusion DisorderUnited States
-
Seoul National University HospitalCHA UniversityCompletedComparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy (VALENTINE)Uterine LeiomyomaKorea, Republic of
-
Advocate Health CareWithdrawn
-
University Hospitals Cleveland Medical CenterWithdrawn
-
James K. Rilling, PhDEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed